{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T10:52:11Z","timestamp":1788000731555,"version":"build-2784847793"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1097\/01.crd.0000260270.12829.45","type":"journal-article","created":{"date-parts":[[2007,4,10]],"date-time":"2007-04-10T04:02:40Z","timestamp":1176177760000},"page":"154-161","source":"Crossref","is-referenced-by-count":36,"title":["Varenicline: A Selective \u03b14\u03b22 Nicotinic Acetylcholine Receptor Partial Agonist Approved for Smoking Cessation"],"prefix":"10.1097","volume":"15","author":[{"given":"Sum","family":"Lam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priti N.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210203","first-page":"1124","article-title":"Cigarette smoking among adults\u2014United States, 2004.","volume":"54","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R2-7-20210203","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/jama.291.10.1238","article-title":"Actual causes of death in the United States, 2000.","volume":"291","author":"Mokdad","year":"2004","journal-title":"JAMA"},{"key":"R3-7-20210203","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1360-0443.2004.00540.x","article-title":"Shape of the relapse curve and long-term abstinence among untreated smokers.","volume":"99","author":"Hughes","year":"2004","journal-title":"Addiction"},{"key":"R4-7-20210203","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/bmj.321.7257.355","article-title":"Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library.","volume":"321","author":"Lancaster","year":"2000","journal-title":"Br Med J"},{"key":"R5-7-20210203","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/bmj.328.7438.509","article-title":"Bupropion and other non-nicotine pharmacotherapies.","volume":"328","author":"Roddy","year":"2004","journal-title":"Br Med J"},{"key":"R6-7-20210203","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3322\/canjclin.55.5.281","article-title":"Pharmacotherapy for nicotine dependence.","volume":"55","author":"Henningfield","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"R7-7-20210203","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/01.crd.0000172309.06270.25","article-title":"Nicotine and non-nicotine smoking cessation and pharmacotherapies.","volume":"14","author":"Frishman","year":"2006","journal-title":"Cardiol Rev"},{"key":"R8-7-20210203","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1021\/jm050069n","article-title":"Varenicline: an \u03b14\u03b22 nicotinic receptor partial agonist for smoking cessation.","volume":"48","author":"Coe","year":"2005","journal-title":"J Med Chem"},{"key":"R9-7-20210203","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1368-5031.2006.00955.x","article-title":"The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline.","volume":"60","author":"Foulds","year":"2006","journal-title":"Int J Clin Pract"},{"key":"R10-7-20210203","article-title":"Chantix (varenicline tablets) [package insert].","year":"2006"},{"key":"R11-7-20210203","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1124\/dmd.105.006767","article-title":"Metabolism and disposition of varenicline, a selective \u03b14\u03b22 nicotinic receptor partial agonist, in vivo and in vitro.","volume":"34","author":"Obach","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"R12-7-20210203","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1177\/0091270006290669","article-title":"Single-dose pharmacokinetics of varenicline, a selective nicotinic receptor partial agonist, in healthy smokers and nonsmokers.","volume":"46","author":"Faessel","year":"2006","journal-title":"J Clin Pharmacol"},{"key":"R13-7-20210203","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archpsyc.1986.01800030107013","article-title":"Signs and symptoms of tobacco withdrawal.","volume":"43","author":"Hughes","year":"1986","journal-title":"Arch Gen Psychiatry"},{"key":"R14-7-20210203","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/14622200020032051","article-title":"Evaluation of the Brief Questionnaire of Smoking Urges (QSU-Brief) in laboratory and clinical settings.","volume":"3","author":"Cox","year":"2001","journal-title":"Nicotine Tob Res"},{"key":"R15-7-20210203","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S1098-3015(10)62877-X","article-title":"Confirmatory factor analysis and reliability of the \u201csmoking effects inventory. \u201d","volume":"8","author":"Cappelleri","year":"2005","journal-title":"Value Health"},{"key":"R16-7-20210203","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/archinte.166.15.1561","article-title":"Smoking cessation with varenicline, a selective \u03b14\u03b22 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.","volume":"166","author":"Nides","year":"2006","journal-title":"Arch Intern Med"},{"key":"R17-7-20210203","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/archinte.166.15.1571","article-title":"Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.","volume":"166","author":"Oncken","year":"2006","journal-title":"Arch Intern Med"},{"key":"R18-7-20210203","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.296.1.47","article-title":"Varenicline, an \u03b14\u03b22 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation.","volume":"296","author":"Gonzales","year":"2006","journal-title":"JAMA"},{"key":"R19-7-20210203","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.296.1.56","article-title":"Efficacy of varenicline, an \u03b14\u03b22 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation.","volume":"296","author":"Jorenby","year":"2006","journal-title":"JAMA"},{"key":"R20-7-20210203","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.296.1.64","article-title":"Effect of maintenance therapy with varenicline on smoking cessation.","volume":"296","author":"Tonstad","year":"2006","journal-title":"JAMA"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00045415-200705000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:35:31Z","timestamp":1786034131000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00045415-200705000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/01.crd.0000260270.12829.45","relation":{},"ISSN":["1061-5377"],"issn-type":[{"value":"1061-5377","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}